Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant

被引：0
|
作者：
Alison E. Mackie
Jo E. McDowall
Pietro Ventresca
Alan Bye
Christine Falcoz
Peter T. Daley-Yates
机构：
[1] Lilly Research Centre,Clinical Pharmacology
[2] Glaxo Wellcome Research and Development,undefined
[3] Glaxo Wellcome Research and Development,undefined
来源：
Clinical Pharmacokinetics | 2000年 / 39卷
关键词：
Fluticasone Propionate; Absolute Bioavailability; Chlorofluorocarbon; Urinary Cortisol; Urinary Cortisol Excretion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 22
页数：5
相关论文
共 42 条
  • [21] Fluticasone Propionate via Diskus™ Inhaler at Half the Microgram Dose of Budesonide via Turbuhaler™ Inhaler
    R. Backman
    C. Baumgarten
    R. K. Sharma
    Clinical Drug Investigation, 2001, 21 : 735 - 743
  • [22] In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler
    Nair, Arun
    Menzies, Daniel
    Hopkinson, Pippa
    McFarlane, Lesley
    Lipworth, Brian J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (02) : 191 - 198
  • [23] Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: A 52-week, open-label, stratified, parallel-group, multicenter study
    Cowie, Robert L.
    Boulet, Louis-Philippe
    Keith, Paul K.
    Scott-Wilson, Catherine A.
    House, Karen W.
    Dorinsky, Paul M.
    CLINICAL THERAPEUTICS, 2007, 29 (07) : 1390 - 1402
  • [24] Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma
    Ayres, JG
    Millar, AB
    Sykes, AP
    RESPIRATORY MEDICINE, 2000, 94 : S42 - S50
  • [25] Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma
    Perruchoud, AP
    Lundback, B
    Yigla, M
    Sykes, AP
    RESPIRATORY MEDICINE, 2000, 94 : S35 - S41
  • [26] Clinical efficacy and safety of fluticasone propionate 250 μg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma
    Tonnel, AB
    Bons, J
    Legendre, M
    Prud'Homme, A
    Bugnas, B
    Evano-Celli, I
    Stuart, AM
    RESPIRATORY MEDICINE, 2000, 94 : S29 - S34
  • [27] Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: A controlled trial
    Blumenthal, MN
    Casale, TB
    Fink, JN
    Uryniak, T
    Casty, FE
    Fineman, SM
    Floreani, AA
    Gadde, J
    Grady, J
    Grossman, J
    Howland, WG
    Klimas, JT
    Pierantoni, W
    Prenner, B
    Raphael, G
    Rowe, MS
    Ruff, DA
    Steinberg, P
    Stricker, WE
    Weerasinghe, M
    Westley, CR
    Winder, J
    Zeitz, HJ
    Harper, A
    Birdsall, D
    Farrar, JR
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : 7 - 13
  • [28] A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma
    Nathan, RA
    Li, JTC
    Finn, A
    Jones, R
    Payne, JE
    Wolford, JP
    Harding, SM
    CHEST, 2000, 118 (02) : 296 - 302
  • [29] Once-daily ciclesonide via metered-dose inhaler: Similar efficacy and safety with or without a spacer
    Engelstaetter, Renate
    Szlavik, M.
    Gerber, Claudia
    Beck, Ekkehard
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1643 - 1650
  • [30] Comparison of systemic pharmacodynamic effects of two combination pressurized metered dose inhalers that deliver salmeterol and fluticasone propionate
    Harrison, Lester I.
    Sessions, Victoria
    Wiggenhorn, Christopher J.
    Chalmers, David
    Leung, Pui
    Efthimiou, John
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (11) : 2377 - 2385
12345